7/25/2019 Cipla Share Price trading near its Current Month High of Rs. 499

1/2

Cipla Share Price trading near its Current Month High of Rs. 499

Introduction:

Cipla is amongst the top pharmaceutical companies in India, which has a goal to ensure

that no patient should be denied access to affordable and high quality medicine and

support.

Mission:

Its mission is to be a leading global healthcare company that uses innovation and

technology to meet day-to-day needs of all patients.

Market Analysis:

Cipla Share Price is currently trading at Rs. 502.00 on National Stock Exchange, very

close to its Current Month High of Rs. 499.00 (29th

June 2016).

The 52 week high of Cipla share price is Rs.745.00 (Dated: 17-Aug-15) while the 52

week low stands at Rs.457.45 (Dated: 25-May-16).

The Market Cap of Cipla Share amounts to 38295.79 crores.

Cipla has not made any losses in the last 2 quarters and has a pledge less than 25%.

History

Cipla was born out of Dr. K.A. Hamieds vision to harness and enhance Indian expertise

for self-sufficiency in the Indian pharmaceutical and chemical industry. Dr. K.A. Hamied

was an matchless visionary who donned numerous hats. He was a chemist, an active

participant in Indias freedom struggle, a close ally of the Father of the Nation,

Mahatma Gandhi, Dr. Zakir Hussain and many others, an entrepreneur and pioneer,

Sheriff of Bombay, proactive supporter and sponsor of scientific institutes in India, head

of various associations, a legislator in the Bombay Presidency.

Be it the beginning of bulk drug production in India, the landmark Indian Patents Act

(1970), the several firsts in the nation and around the globe, its historic international

stance on the availability and price of antiretroviral drugs for HIV treatment in

2000-2001 and its free-of-cost Palliative Care Centre for terminally-ill cancer patients,

7/25/2019 Cipla Share Price trading near its Current Month High of Rs. 499

2/2

Cipla, under the leadership of its present Chairman Dr. Y K Hamied, has stood for

compassion and fearlessness. Cipla truly means when it says None Shall be Denied.

Apart from its numerous national and international milestones, Ciplas growth and

expansion, its ups and downs, challenges and successes is one that deserves to be

chronicled too. Cipla was ranked 56 in the 1960s, says Dr Y K Hamied.

Cipla believes that their work is not just about making medicines but its about making a

difference.

Research and development department of Cipla:

Cipla New Ventures (CNV)

The pharmaceutical world is witnessing significant shifts:

Towards finding new value in old drugs

Towards biology-based medicine

Towards prevention, self-care and wellness.

Last year, Cipla launched Cipla New Ventures (CNV) as its impact investment arm, to

build and nurture innovation-led business streams, distinct from the mainstreambusiness of Cipla of today and tomorrow.

Support and Resistance Levels of Cipla:

The closest support level of Cipla Share is Rs.457.45 while the closest resistance level is

Rs.492.55.

For more information on Cipla, kindly visit Cipla Share Price Forecast and Cipla Share

Price History.